Meeting
2020 ASCO Virtual Scientific Program
RELAY study of erlotinib (ERL) + ramucirumab (RAM) or placebo (PL) in EGFR-mutated metastatic non-small cell lung cancer (NSCLC): Biomarker analysis using circulating tumor DNA (ctDNA) in Japanese patients (pts).
Authors
Kazuto Nishio
Department of Genome Biology, Kindai University Faculty of Medicine, Osaka, Japan
Kazuto Nishio , Kazuko Sakai , Takashi Seto , Makoto Nishio , Edward B. Garon , Martin Reck , Koichi Goto , Terufumi Kato , Yoichi Nakanishi , Toshiaki Takahashi , Nobuyuki Yamamoto , Katsuyuki Kiura , Yuichiro Ohe , Tomohide Tamura , Carla M Visseren-Grul , Rebecca R. Hozak , Sameera R. Wijayawardana , Sotaro Enatsu , Kazuhiko Nakagawa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Biologic Correlates
Clinical Trial Registration Number
NCT02411448
Citation
J Clin Oncol 38: 2020 (suppl; abstr 9527)
DOI
10.1200/JCO.2020.38.15_suppl.9527
Abstract #
9527
Poster Bd #
293
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Dissecting the genomic landscape of metastatic bladder cancer using circulating tumor DNA.
First Author: Werner J. Struss
Poster
2023 ASCO Annual Meeting
First results from the RETgistry: A global consortium for the study of resistance to RET inhibition in RET-altered solid tumors.
First Author: Alissa Jamie Cooper
Poster
2019 ASCO-SITC Clinical Immuno-Oncology Symposium
Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer.
First Author: Nicolas Guibert
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock